Ursula Felderhoff‐Müser
Neonatal hypoglycemia is among the most common problems in neonatology, however uncertainty about optimal thresholds and the duration of monitoring persist. Balasundaram et al. report the results of a multicentre well-defined prospective cohort study assessing neurodevelopmental outcomes at 18–24 months’ corrected age in late preterm born infants (≥35–36/6 weeks’ gestation, ≥2000 g) who were either hypoglycemic or euglycemic according to American Academy of Pediatrics (AAP) screening guidelines during the first 24 h of life.